Exagen Stock Options
| XGN Stock | USD 1.82 0.03 1.62% |
Exagen's latest option contracts expiring on 2024-07-19 have a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-07-19. The Exagen option chain provides detailed quote and price information for the current Exagen Inc option contracts. It shows all of Exagen's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Exagen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Exagen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Exagen's option, there is no secondary market available for investors to trade.
Exagen's option chain provides insight into all available option contracts written on Exagen's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Exagen's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Exagen option contract.
In The Money vs. Out of Money Option Contracts on Exagen
Analyzing Exagen's in-the-money options over time can help investors to take a profitable long position in Exagen regardless of its overall volatility. This is especially true when Exagen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Exagen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Exagen's stock while costing only a fraction of its price.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note that buying 'in-the-money' options on Exagen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Exagen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Exagen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Exagen Stock moves the wrong way.
At this time, Exagen's Common Stock Shares Outstanding is very stable compared to the past year. As of the 29th of June 2024, Stock Based Compensation is likely to grow to about 3.8 M, while Total Stockholder Equity is likely to drop about 20.5 M. Exagen Current Options Market Mood
Exagen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Exagen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Exagen's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Exagen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Exagen's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Exagen contract
Base on the Rule 16, the options market is currently suggesting that Exagen Inc will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-07-19 option contract. With Exagen trading at USD 1.82, that is roughly USD 0.0. If you think that the market is fully incorporating Exagen's daily price movement you should consider buying Exagen Inc options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Exagen |
Purchasing Exagen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Exagen calls. Remember, the seller must deliver Exagen Inc stock to the call owner when a call is exercised.
Exagen Market Cap Over Time
Market Cap |
| Timeline |
Exagen Total Stockholder Equity
Total Stockholder Equity |
|
Exagen Corporate Management
| Debra Zack | Chief Officer | Profile | |
| John Wegener | Senior Marketing | Profile | |
| Ryan Douglas | Investors Officer | Profile | |
| Mark Hazeltine | Chief Officer | Profile | |
| MingChou Lee | Chief Officer | Profile | |
| Michael MD | Chief Officer | Profile |
Additional Information and Resources on Investing in Exagen Stock
When determining whether Exagen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Exagen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Exagen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Exagen Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exagen. If investors know Exagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 3.134 | Quarterly Revenue Growth 0.284 | Return On Assets (0.17) | Return On Equity (0.69) |
The market value of Exagen Inc is measured differently than its book value, which is the value of Exagen that is recorded on the company's balance sheet. Investors also form their own opinion of Exagen's value that differs from its market value or its book value, called intrinsic value, which is Exagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exagen's market value can be influenced by many factors that don't directly affect Exagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.